% The Company and its subsidiaries had other income of Baht 741.35 million, a rise by Baht 375.49 million or 102.63% from the same period of last year. Most of the increase came from the interest income
14.36 hrs. on September 26, 2011, SET Index was at 867.94 and soared six minutes after the reopenning. SET Index?s closed at 904.06, or a surge of 36.12, a 4.16 percent rise after the halt. It was found
www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the
”) reported 2019 total revenue of THB 12,275m, increased by 63% YoY. Major drivers of such growth were 104% increase in revenue from sales of house and condominium together with 27% increase in revenue from
Page 1 of 4 No. RJH – SET 8/2019 13 May 2019 Subject : Management’s Discussion and Analysis for the First Quarter of 2019 To : The President The Stock Exchange of Thailand Rajthanee Hospital Public
house and condominium unit attributed to the rise in total revenue. 3Q19 Net profit at THB 222m, or 38% decline YoY, primarily due to gain from exchange rate at THB 312m realized in 3Q18. The ESSE at
together with a rise in revenues from sales of wellness and anti-aging Business Unit at Baht 128.58 million or increase of Baht 34.12 million or 26.54% in 2019 largely from sales of probiotic products such
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like